Record Q2 with 10%+ pump shipment growth, 6% sales increase, and 57% gross margin. Pharmacy channel adoption reached 10% of U.S. sales, with strong international growth and new technology launches. Guidance for 2026 reaffirmed, with highest margins expected in Q4.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.